However, numerous tumors develop resistance to immunotherapy through immune evasion mechanisms and the upregulation of immune checkpoints, such as PD-L1 or CTLA-4, which hinder the immune system’s ability to recognize and destroy tumor cells (Peng et al., 2019; Menzies et al., 2022; Pardoll, 2012). Here, CD274 is linked to neoplasm.